Related Experiment Video
Updated: Jun 8, 2026
08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
17.9K
Editorial on Special Issue "Lipid Nanosystems for Local Drug Delivery"
José Catita1,2, Carla M Lopes1,3,4
1Instituto de Investigação, Inovação e Desenvolvimento (FP-I3ID), Biomedical and Health Sciences Research Unit (FP-BHS), Faculdade Ciências da Saúde, Universidade Fernando Pessoa, 4200-150 Porto, Portugal.
Pharmaceutics
|July 29, 2023
Summary
Nanosystems offer a promising avenue for drug delivery, improving therapeutic performance and overcoming limitations of traditional treatments. These advanced systems enhance existing drug formulations for better patient outcomes.
Area of Science:
- Pharmacology
- Materials Science
- Nanotechnology
Background:
- Conventional therapies face limitations in efficacy and delivery.
- Nanosystems present a novel platform for advanced pharmacological applications.
- The integration of nanosystems can significantly improve drug formulation performance.
Discussion:
- Nanosystems offer enhanced drug targeting and controlled release mechanisms.
- They can overcome biological barriers, improving bioavailability.
- The potential for reduced side effects and improved patient compliance is significant.
Key Insights:
- Nanosystems enhance the performance of pharmacological therapies.
- They address constraints associated with conventional drug delivery methods.
- Value is added to existing drug formulations through nanocarrier integration.
Outlook:
- Further research into specific nanosystem designs for targeted diseases.
- Clinical translation and large-scale manufacturing of nanomedicines.
- Exploration of synergistic effects between nanocarriers and therapeutic agents.
More Related Videos
Related Concept Videos
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...